首页> 美国卫生研究院文献>Neuro-Oncology >Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors
【2h】

Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors

机译:全球DNA甲基化分析显示miR-214-3p有助于小儿颅内非生殖细胞恶性生殖细胞肿瘤中的顺铂耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPediatric central nervous system germ cell tumors (CNSGCTs) are rare and heterogeneous neoplasms, which can be divided into germinomas and nongerminomatous germ cell tumors (NGGCTs). NGGCTs are further subdivided into mature teratomas and nongerminomatous malignant GCTs (NGMGCTs). Clinical outcomes suggest that NGMGCTs have poor prognosis and survival and that they require more extensive radiotherapy and adjuvant chemotherapy. However, the mechanisms underlying this difference are still unclear. DNA methylation alteration is generally acknowledged to cause therapeutic resistance in cancers. We hypothesized that the pediatric NGMGCTs exhibit a different genome-wide DNA methylation pattern, which is involved in the mechanism of its therapeutic resistance.
机译:背景小儿中枢神经系统生殖细胞肿瘤(CNSGCT)是罕见的异质性肿瘤,可分为生殖细胞瘤和非生殖细胞生殖细胞肿瘤(NGGCT)。 NGGCT进一步细分为成熟的畸胎瘤和非生殖器恶性GCT(NGMGCT)。临床结果表明,NGMGCT的预后和生存率较差,需要更广泛的放疗和辅助化疗。但是,这种差异的潜在机制仍不清楚。人们普遍认为DNA甲基化改变会引起癌症的治疗抗性。我们假设儿科NGMGCTs表现出不同的全基因组DNA甲基化模式,这涉及其治疗抗性的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号